Chondrial Therapeutics
is a biotechnology company that discovers and develops orphan drugs for the treatment of mitochondrial diseases... Read moreChondrial Therapeutics
is a biotechnology company that discovers and develops orphan drugs for the treatment of mitochondrial diseases... Read more
President & CEO
Carole Ben-Maimon
News
May 29, 2020
The Business Journals: Philadelphia
Chondrial Therapeutics: Montgomery County biotech firm completes reverse merger, raises $77.8 million
May 29, 2020
The Pharma Letter
Chondrial Therapeutics: BRIEF-Chondrial Therapeutics and Zafgen complete merger
Dec 20, 2019
The Business Journals: Philadelphia
Chondrial Therapeutics: Montco biopharm firm merging with Boston drug developer, creating new public company
Dec 18, 2019
Xconomy
Chondrial Therapeutics: Zafgen's Path Forward Is Reverse Merger With Chondrial Therapeutics
Dec 18, 2019
GlobeNewswire
Press Release: Chondrial Therapeutics : Chondrial Therapeutics Announces Dosing of First Patients in Phase 1 Clinical Program of CTI-1601 for Treatment of Friedreich's Ataxia
Dec 18, 2019
MARKET EXCLUSIVE
Chondrial Therapeutics: Zafgen, Inc. (NASDAQ:ZFGN) Files An 8-K Entry into a Material Definitive Agreement
May 20, 2019
The Business Journals: Philadelphia
Chondrial Therapeutics: Exclusive: Bala Cynwyd company raises $25.8M
Aug 06, 2017
BioPortfolio
Chondrial Therapeutics: US FDA grants orphan drug status to Chondrial Therapeutics' CTI1601 to treat Friedreich's Ataxia
Feb 09, 2017
BioPortfolio
Chondrial Therapeutics: Chondrial Therapeutics Raises Up to $22.6M in Series A Financing
Feb 07, 2017
BioCentury
Chondrial Therapeutics: Chondrial raising $22.6M, gets Friedreich's candidate
Chondrial Therapeutics Competitors
1
2
3
4
5
6
7
8
9
10